In addition, ASCs/MSCs are capable of modulating the metabolism of breast cancer cells by stimulating, for example, the upregulation of cluster of differentiation 36 (CD36), a fatty acid receptor, leading to an increased proliferation rate [113], or the upregulation of S100 calcium-binding protein A7, involved in cell cycle regulation [114]. Here, CD36 is linked to breast cancer.